NEXGEL, Inc. (NXGL)

CIK 0001468929 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
FY-2025
Latest FY-2025 —
Q3-2025 8-K (2025-11-12) · 99.1 · 99.2
Q2-2025 8-K (2025-08-12) · 99.1 · 99.2
Q1-2025 8-K (2025-05-13) · 99.1
FY-2024 8-K (2025-03-24) · 99.1  |  8-K (2025-01-22) · 99.1  |  8-K (2024-11-14) · 99.1
Q3-2024 8-K (2024-10-10) · 99.1
Q2-2024 8-K (2024-08-14) · 99.1  |  8-K (2024-07-08) · 99.1
FY-2023
Q1-2024 8-K (2024-05-13) · 99.1
FY-2023 8-K (2024-04-01) · 99.1
Q3-2023 8-K (2023-11-13) · 99.1
Q2-2023 8-K (2023-08-14) · 99.1 · 99.2

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (P)
Notes
Accrued Expenses and Other Current Liabilities
Acquisition
Business Segments
Commitments and Contingencies
Common Stock
Concentrations of Risk
Convertible Notes Payable
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business and Basis of Presentation
Description of Business, Stock Split and Basis of Presentation
Financing Lease
Going Concern
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets
Inventory
Investment In Nexgelrx
—
Leases
Noncontrolling Interest In Joint Venture
—
Notes Payable
Operating Leases
Pay Vs Performance Disclosure
Property and Equipment, Net
Related Party Transactions
Share-based Compensation
Significant Accounting Policies and Estimates
Subsequent Events
Variable Interest Entities
Warrant Liability